Last reviewed · How we verify

NCT04031352

Investigation of Factors Affecting Children's Attitudes Towards Peers With Disability

Completed Last updated 24 July 2019
What this trial tests

trial testing implementation of CATCH scale in Disability Physical in 1,305 participants. Completed in 16 June 2018.

Timeline
14 March 2017
Primary endpoint
18 February 2018
16 June 2018

Quick facts

Lead sponsorPamukkale University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment1,305
Start date14 March 2017
Primary completion18 February 2018
Estimated completion16 June 2018
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Pamukkale University

Who can join

Adults 11 to 15, any sex, with Disability Physical. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Children with disabilities can be exposed to stigma and discrimination because of poor attitudes. The role of peer is crucial for development of disabled children. The aim of the study was to investigate the attitudes of children towards their peers with disabilities and to identify factors associated with them. 1305 elementary school students included to the study. The students participating in the study, 48.9% (534) were female, 51.1% (558) were male. The Chedoke-McMaster Attitudes towards Children with Handicaps (CATCH) scale was used to investigate the children's attitudes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Disability Physical

Currently open trials in the same condition.

Other Pamukkale University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04031352.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing